HealthEquity Inc. (NASDAQ:HQY) insider Jon Kessler sold 10,000 shares of HealthEquity stock in a transaction that occurred on Monday, July 25th. The stock was sold at an average price of $29.62, for a total value of $296,200.00. Following the sale, the insider now directly owns 430,000 shares of the company’s stock, valued at $12,736,600. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Jon Kessler also recently made the following trade(s):
- On Friday, July 15th, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $30.05, for a total value of $300,500.00.
Other institutional investors have added to or reduced their stakes in the company. First Trust Advisors LP acquired a new position in HealthEquity during the fourth quarter valued at about $1,969,000. Russell Frank Co raised its position in shares of HealthEquity by 21.0% in the fourth quarter. Russell Frank Co now owns 229,025 shares of the company’s stock valued at $5,980,000 after buying an additional 39,790 shares during the period. California State Teachers Retirement System raised its position in shares of HealthEquity by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 67,182 shares of the company’s stock valued at $1,684,000 after buying an additional 1,038 shares during the period. Finally, Rhumbline Advisers raised its position in shares of HealthEquity by 10.0% in the fourth quarter. Rhumbline Advisers now owns 40,982 shares of the company’s stock valued at $1,027,000 after buying an additional 3,720 shares during the period.
HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, June 7th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.02. The business earned $44.01 million during the quarter. The firm’s quarterly revenue was up 47.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.10 earnings per share. Equities research analysts anticipate that HealthEquity Inc. will post $0.48 EPS for the current fiscal year.
HQY has been the subject of several analyst reports. Zacks Investment Research cut HealthEquity from a “buy” rating to a “hold” rating in a report on Friday, April 22nd. SunTrust Banks Inc. lifted their price objective on HealthEquity from $34.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, June 8th. TheStreet raised HealthEquity from a “sell” rating to a “hold” rating in a report on Tuesday, June 7th. Leerink Swann lifted their price objective on HealthEquity from $26.00 to $30.00 and gave the company an “outperform” rating in a report on Monday, April 4th. Finally, Wells Fargo & Co. reaffirmed a “buy” rating on shares of HealthEquity in a report on Wednesday, June 8th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. HealthEquity has a consensus rating of “Buy” and a consensus target price of $32.60.
HealthEquity, Inc is a provider of a range of solutions for managing health care accounts (Health Savings Accounts (HSAs)), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
